Wikidata:Database reports/Constraint violations/P267
Jump to navigation
Jump to search
Constraint violations report for ATC code (Discussion, uses, items, changes, related properties): therapeutic chemical identification code per ATC
Data time stamp: (UTC) — Items processed: 3,744
The report is generated based on the settings on Property:P267#P2302.
Updates overwrite this page. Some may already be fixed since the last update: check RecentChangesLinked.
When incremental dumps and the bot work as planned, items fixed before 07:00 UTC disappear in the next update. The report is not updated if only the item count changes.
The report can include false positives. There is no need to "fix" them.
Data time stamp: (UTC) — Items processed: 3,744
The report is generated based on the settings on Property:P267#P2302.
Updates overwrite this page. Some may already be fixed since the last update: check RecentChangesLinked.
When incremental dumps and the bot work as planned, items fixed before 07:00 UTC disappear in the next update. The report is not updated if only the item count changes.
The report can include false positives. There is no need to "fix" them.
"Unique value" violations[edit]
Violations count: 76
- A01AB02: hydrogen peroxide (Q171877), hydrogen peroxide solution (Q64878155)
- A02: ATC code A02 (Q239559), drugs for acid-related disorders (Q2608633)
- A03AX08: alverine (Q4116162), alverine citrate (Q27124210)
- A05BA03: silibinin A (Q425702), silymarin (Q60970556)
- A06AD11: β-lactulose (Q422689), LAKTULOSA SANDOZ (Q97479031)
- A07AA01: neomycin (Q423098), Neosporin (Neomycin/polymyxin B/bacitracin) (Q6994170)
- A08: ATC code A08 (Q433777), anti-obesity medication (Q1303753)
- A10: ATC code A10 (Q433796), anti-diabetic medication (Q575062)
- A10AB01: Actrapid (Q2034113), regular insulin (Q2893248)
- A10BD21: saxagliptin / dapagliflozin propanediol (Q28856434), dapagliflozin / saxagliptin (Q48566740)
- A10BJ: glucagon-like peptide-1 (Q424611), glucagon-like peptide-1 agonist (Q5572286)
- A11HA30: DL-panthenol (Q196473), dexpanthenol (Q47495755)
- A12BA01: potassium chloride (Q184630), potassium chloride (Q28453483)
- B01: anticoagulant (Q215118), ATC code B01 (Q433829), antithrombotic (Q4775337)
- B02: ATC code B02 (Q196482), antihemorrhagic (Q1642182)
- B03: ATC code B03 (Q196493), anti-anemic (Q574831)
- B03XA01: epoetin beta (Q5383795), epoetin theta (Q28852443)
- B05AA05: dextran-40 (Q4393309), Dextran 70 (Q28163637)
- B05CA09: neomycin (Q423098), Neosporin (Neomycin/polymyxin B/bacitracin) (Q6994170)
- B05XA02: sodium bicarbonate (Q179731), Intravenous sodium bicarbonate (Q17147112)
- B05XA04: ammonium chloride (Q188543), carbachol (Q419401)
- C02KX01: bosentan (Q419769), bosentan hydrate (Q27114267)
- C03: diuretic (Q200656), ATC code C03 (Q433885)
- C04: ATC code C04 (Q433887), vasodilator agent (Q4008956)
- C05: ATC code C05 (Q433888), vasoprotective (Q4065146)
- C05BB04: myristyl sulfate (Q20817018), sodium myristyl sulfate (Q27255739)
- C07: ATC code C07 (Q385681), beta blocker (Q816759)
- C08: calcium channel blocker (Q421700), ATC code C08 (Q433907)
- C08CA15: (3R,4′RS)-benidipine (Q11336997), rac-benidipine (Q113514917)
- C09BB04: amlodipine / perindopril (Q48566830), PERINDOPRIL/AMLODIPINE STADA (Q97478183), AMLESSA (Q97479028)
- D02: ATC code D02 (Q155757), moisturizer (Q3006091)
- D03AX03: DL-panthenol (Q196473), dexpanthenol (Q47495755)
- D04: ATC code D04 (Q433950), antipruritic (Q2853347)
- D05: ATC code D05 (Q139051), antipsoriatic (Q4775140)
- D08AC05: Polyhexanide (Q408205), 1-(diaminomethylidene)-2-hexylguanidine (Q114905732)
- D08AG03: Iodinolum (Q4205884), iodine (Q28196266)
- D08AX: disinfectant (Q73984), antiseptic (Q274493)
- D10: ATC code D10 (Q143139), acne treatment (Q95359530)
- G03A: contraceptive agents (Q2995702), hormonal contraceptive agents (Q98681544)
- G03AD02: ulipristal acetate (Q975059), ulipristal (Q27264992)
- G03BA03: testosterone (Q1318776), testosterone undecanoate (Q15410178)
- G03CA03: 17β-estradiol (Q422416), 17α/β-estradiol (Q12415847)
- G03GA: gonadotropins (Q409770), Gonadotropin preparations (Q5581328)
- G04: ATC code G04 (Q642633), urological agents (Q50430468)
- H03AA01: L-thyroxine (Q773449), levothyroxine sodium (Q27107208)
- J01EE01: sulfamethoxazole/trimethoprim (Q898623), sulfamethoxazole / trimethoprim (Q48566821)
- J01XA04: dalbavancin (Q5210237), dalbavancin hydrochloride (Q28856123)
- J01XB01: colistin (Q418946), colistimethate sodium (Q25452548)
- J04: ATC code J04 (Q280713), antimycobacterial (Q2853298)
- J06AA03: antivenom (Q424427), Snake antivenom (Q7547113)
- J06BA02: immunoglobulin G (Q79448), Privigen (Q29006371)
- J07: vaccine (Q134808), ATC code J07 (Q3242415)
- J07AM01: DPT vaccine (Q908600), tetanus vaccine (Q5861101)
- J07BB02: Pandemrix (Q1353540), Influvac (Q4202214)
- J07BD54: MMRV vaccine (Q6716846), ProQuad (Q60024476)
- J07BX03: mRNA-1273 vaccine (Q87775025), Ad5-nCoV (Q96695265), CoronaVac (Q97154233), Gam-COVID-Vac (Q98270627), Corbevax (Q106350062)
- L01: ATC code L01 (Q434099), antineoplastic (Q2853144)
- L01AD: nitrosourea (Q418311), nitrosourea compound (Q57712768)
- L01XA: platinum-based antineoplastic (Q7202320), platinum compound (Q74896917)
- L01XE: ALK inhibitor (Q4652380), protein kinase inhibitors (Q7251487)
- M01AH: COX-2 inhibitor (Q377458), cyclooxygenase inhibitors (Q20522059)
- M04: ATC code M04 (Q434151), antigout agent (Q17173047)
- N04: ATC code N04 (Q434194), antiparkinson (Q3579672)
- N05: ATC code N05 (Q434199), psycholeptic (Q2913901)
- N06: ATC code N06 (Q434213), Psychoanaleptic (Q1135452)
- N06BA10: fenethylline hydrochloride (Q415476), fenethylline (Q27887794)
- N07BA01: nicotine (Q12144), nicotine replacement therapy (Q1189783)
- P01: ATC code P01 (Q278523), antiprotozoal (Q582559)
- P02: ATC code P02 (Q434231), anthelmintic (Q572294)
- R03AC03: terbutaline (Q424340), Q10435528
- R03AK09: mometasone/formoterol (Q6897268), formoterol / mometasone (Q48719715)
- R05: ATC code R05 (Q434273), common cold treatment (Q11607580)
- S01EE01: latanoprost (Q634959), latanoprost acid (Q27078867)
- S01XA12: DL-panthenol (Q196473), dexpanthenol (Q47495755)
- V03AE01: polystyrene sulfonate (Q3395465), Divinylbenzene-styrenesulfonic acid copolymer (Q72470253)
- V08: ATC code V08 (Q1348349), contrast agent (Q6849688)
"Format" violations[edit]
Violations count: 0
"Entity types" violations[edit]
Violations count: 0
"Scope" violations[edit]
Violations count: 0